Corindus Vascular Robotics (CVRS) Shares Gap Up to $1.84

Corindus Vascular Robotics Inc (NYSEAMERICAN:CVRS)’s share price gapped up before the market opened on Friday . The stock had previously closed at $1.79, but opened at $1.84. Corindus Vascular Robotics shares last traded at $1.89, with a volume of 2461460 shares.

Corindus Vascular Robotics (NYSEAMERICAN:CVRS) last issued its quarterly earnings data on Tuesday, March 12th. The medical equipment provider reported ($0.04) earnings per share (EPS) for the quarter, hitting the consensus estimate of ($0.04). The firm had revenue of $4.67 million for the quarter, compared to analyst estimates of $5.60 million.

In related news, major shareholder Hudson Executive Capital Lp purchased 2,899,391 shares of the business’s stock in a transaction dated Tuesday, March 12th. The stock was bought at an average cost of $1.38 per share, with a total value of $4,001,159.58. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Louis A. Cannon purchased 573,798 shares of the business’s stock in a transaction dated Tuesday, March 12th. The stock was bought at an average cost of $1.38 per share, with a total value of $791,841.24. The disclosure for this purchase can be found here.

A number of institutional investors have recently added to or reduced their stakes in CVRS. Citadel Advisors LLC increased its stake in Corindus Vascular Robotics by 205.4% in the third quarter. Citadel Advisors LLC now owns 115,728 shares of the medical equipment provider’s stock valued at $164,000 after purchasing an additional 77,829 shares during the last quarter. Virtu Financial LLC purchased a new stake in Corindus Vascular Robotics during the fourth quarter valued at about $64,000. Nomura Holdings Inc. grew its position in Corindus Vascular Robotics by 18.6% during the fourth quarter. Nomura Holdings Inc. now owns 1,262,445 shares of the medical equipment provider’s stock valued at $1,077,000 after acquiring an additional 198,111 shares during the period. Barclays PLC purchased a new stake in Corindus Vascular Robotics during the fourth quarter valued at about $325,000. Finally, Jane Street Group LLC purchased a new stake in Corindus Vascular Robotics during the fourth quarter valued at about $36,000.

COPYRIGHT VIOLATION NOTICE: “Corindus Vascular Robotics (CVRS) Shares Gap Up to $1.84” was posted by Chaffey Breeze and is the property of of Chaffey Breeze. If you are viewing this news story on another publication, it was copied illegally and reposted in violation of US & international copyright & trademark legislation. The original version of this news story can be accessed at https://www.chaffeybreeze.com/2019/03/23/corindus-vascular-robotics-cvrs-shares-gap-up-to-1-84.html.

About Corindus Vascular Robotics (NYSEAMERICAN:CVRS)

Corindus Vascular Robotics, Inc designs, manufactures, and sells robotic-assisted precision vascular systems for use in interventional vascular procedures in the United States and internationally. The company offers CorPath system, a medical device with robotic-assisted precision for radial, coronary, and peripheral procedures.

Read More: Dividend

Receive News & Ratings for Corindus Vascular Robotics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Corindus Vascular Robotics and related companies with MarketBeat.com's FREE daily email newsletter.